• Explore /
  • Poster
  • / Use of genetic variants in wnt signaling pathway to predict gender and tumor location dependent survival in metastatic colorectal cancer (mCRC) patients (pts) treated with first-line FOLFIRI and bevacizumab (BEV).

Use of genetic variants in wnt signaling pathway to predict gender and tumor location dependent survival in metastatic colorectal cancer (mCRC) patients (pts) treated with first-line FOLFIRI and bevacizumab (BEV).

Abstract Poster

Authors

null

Yan Ning

University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA

Yan Ning , Wu Zhang , Dongyun Yang , Fotios Loupakis , Takeru Wakatsuki , Sebastian Stintzing , Nico Benjamin Volz , Joseph Ethan Li , Rita Elie El-Khoueiry , Melissa Janae Labonte , Chiara Cremolini , Federica Marmorino , Afsaneh Barzi , Anthony B. El-Khoueiry , Heinz-Josef Lenz , Michael Kahn

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Citation

J Clin Oncol 31, 2013 (suppl; abstr 3568)

DOI

10.1200/jco.2013.31.15_suppl.3568

Abstract #

3568

Poster Bd #

5B

Abstract Disclosures

Similar Posters

First Author: Yan Ning

First Author: Madiha Naseem

First Author: Alberto Puccini

First Author: Ryuma Tokunaga